Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Cargo

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Lancet. Rheumatology|May 24, 2025
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort studyAdam Al-Hakim, Roochi Trikha, Ei Ei Phyu Htut, et al.
Blood|June 11, 2020
Germline TET2 loss of function causes childhood immunodeficiency and lymphomaJarmila Stremenova Spegarova, Dylan Lawless, Siti Mardhiana Binti Mohamad, et al.
Nature|October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisAkihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.
Leukemia|December 22, 2018
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophiliaNicholas C P Cross, Yvette Hoade, William J Tapper, et al.
Blood|July 6, 2022
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesisMarcela A Ferrada, Sinisa Savic, Daniela Ospina Cardona, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Hemasphere|May 17, 2024
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina A Tentori, Lin P Zhao, Benedetta Tinterri, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Lancet. Rheumatology|May 24, 2025
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort studyAdam Al-Hakim, Roochi Trikha, Ei Ei Phyu Htut, et al.
Blood|June 11, 2020
Germline TET2 loss of function causes childhood immunodeficiency and lymphomaJarmila Stremenova Spegarova, Dylan Lawless, Siti Mardhiana Binti Mohamad, et al.
Nature|October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisAkihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.
Leukemia|December 22, 2018
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophiliaNicholas C P Cross, Yvette Hoade, William J Tapper, et al.
Blood|July 6, 2022
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesisMarcela A Ferrada, Sinisa Savic, Daniela Ospina Cardona, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Hemasphere|May 17, 2024
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina A Tentori, Lin P Zhao, Benedetta Tinterri, et al.
Pageof 3